Advanced BioMedical Technologies, Inc.
ABMT
$0.0003
$0.000150.00%
| 07/31/2021 | 04/30/2021 | 01/31/2021 | 10/31/2020 | 07/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 3.17% | 9.82% | -169.59% | 21.96% | 3.62% |
| Total Depreciation and Amortization | 137.50% | -15.65% | -1.88% | 208.16% | -383.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -97.07% | -59.09% | 85.11% | 160.33% | 1,181.25% |
| Change in Net Operating Assets | -61.17% | -13.79% | -4,120.69% | 2,666.46% | 247.61% |
| Cash from Operations | -179.88% | 4.97% | -891.91% | 490.75% | 183.11% |
| Capital Expenditure | -42.86% | -13.00% | -3,540.00% | -106.45% | 70.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -42.86% | -13.00% | -3,540.00% | -106.45% | 70.21% |
| Total Debt Issued | 203.67% | -10.18% | 433.53% | -165.17% | -169.69% |
| Total Debt Repaid | 67.27% | 89.81% | -93.46% | -- | -334.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 11.11% | 36.36% | 53.85% | -- | -- |
| Cash from Financing | 186.29% | -5.39% | 511.50% | -433.02% | -176.55% |
| Foreign Exchange rate Adjustments | 300.00% | 700.00% | 4,600.00% | -- | 300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -73.68% | -196.15% | -7,828.00% | 3,632.08% | 480.00% |
